Austerman Joseph
Center for Pediatric Behavioral Health, Cleveland Clinic Children's, Cleveland, OH, USA. E-mail:
Cleve Clin J Med. 2015 Nov;82(11 Suppl 1):S2-7. doi: 10.3949/ccjm.82.s1.01.
Behavioral disorders in pediatric patients--primarily attention deficit hyperactivity disorder (ADHD)--pose a clinical challenge for health care providers to accurately assess, diagnose, and treat. In 2013, updated diagnostic criteria for behavioral disorders were published, including ADHD and a new diagnostic entity: disruptive mood dysregulation disorder. Revised criteria for ADHD includes oldest age for occurrence of symptoms, need for symptoms to be present in more than one setting, and requirement for number of symptoms in those aged 17 and older. Assessment of ADHD relies primarily on the clinical interview, including the medical and social history, along with the aid of objective measures. The clinical course of ADHD is chronic with symptom onset occurring well before adolescence. Most patients have symptoms that continue into adolescence, and some into adulthood. Many patients with ADHD have comorbid disorders such as depression, disruptive behavior disorders, or substance abuse, which need to be addressed first in the treatment plan. Treatment of ADHD relies on a combination of psychopharmacologic, academic, and behavioral interventions, which produce response rates up to 80%.
儿科患者的行为障碍——主要是注意力缺陷多动障碍(ADHD)——给医疗保健提供者准确评估、诊断和治疗带来了临床挑战。2013年,发布了行为障碍的更新诊断标准,包括ADHD和一个新的诊断实体:破坏性行为失调障碍。ADHD的修订标准包括症状出现的最大年龄、症状需在不止一种环境中出现,以及17岁及以上患者症状数量的要求。ADHD的评估主要依靠临床访谈,包括病史和社会史,并借助客观测量手段。ADHD的临床病程是慢性的,症状在青春期前就已出现。大多数患者的症状会持续到青春期,有些会持续到成年期。许多ADHD患者伴有共病,如抑郁症、破坏性行为障碍或药物滥用,这些在治疗计划中需要首先得到解决。ADHD的治疗依靠心理药理学、学业和行为干预的联合应用,有效率可达80%。